Chimeric Therapeutics Limited (CHM.AX)
AUD 0.0
(-20.0%)
AUD 0.0
(-20.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 7.45 Million AUD | 65.52% |
| 2023 | 4.5 Million AUD | 72.16% |
| 2022 | 2.61 Million AUD | 98808.62% |
| 2021 | 2646.00 AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | -1.75 Million AUD | -132.02% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 5.48 Million AUD | 0.0% |
| 2024 Q1 | 5.48 Million AUD | 677.15% |
| 2024 Q4 | -1.75 Million AUD | 0.0% |
| 2023 Q1 | 1.5 Million AUD | 15.01% |
| 2023 Q2 | 1.5 Million AUD | 0.0% |
| 2023 Q4 | 705.81 Thousand AUD | 0.0% |
| 2023 Q3 | 705.81 Thousand AUD | -53.1% |
| 2023 FY | 4.5 Million AUD | 72.16% |
| 2022 Q4 | 1.3 Million AUD | 0.0% |
| 2022 Q3 | 1.3 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2022 FY | 2.61 Million AUD | 98808.62% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | 2646.00 AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -329.144% |
| Acrux Limited | 5.09 Million AUD | -46.487% |
| Actinogen Medical Limited | 9.93 Million AUD | 24.909% |
| AnteoTech Limited | 460.39 Thousand AUD | -1519.832% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -187.061% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -43768.576% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | -85.547% |
| Amplia Therapeutics Limited | 4.45 Million AUD | -67.485% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -1474.837% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -40607.74% |
| Biome Australia Limited | 13 Million AUD | 42.673% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -1139.184% |
| BTC Health Limited | 16.36 Thousand AUD | -45484.707% |
| CSL Limited | 22.41 Billion AUD | 99.967% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 35.188% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 91.543% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -222.056% |
| Dimerix Limited | 583.47 Thousand AUD | -1178.139% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 88.776% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -495.862% |
| Immuron Limited | 4.9 Million AUD | -52.108% |
| Immutep Limited | 3.5 Million AUD | -112.728% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -515.188% |
| Memphasys Limited | 60 Thousand AUD | -12329.43% |
| Nanollose Limited | 12.5 Thousand AUD | -59556.491% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 96.784% |
| Noxopharm Limited | 2.4 Million AUD | -210.7% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 5.31 Million AUD | -40.304% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | 1.39 Million AUD | -434.92% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -11233.827% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -735.926% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -100.887% |
| PYC Therapeutics Limited | 22.05 Million AUD | 66.193% |
| Race Oncology Limited | 4 Million AUD | -86.28% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -2392.3% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 8.28 Million AUD | 10.029% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 98.498% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -4798.619% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -7754.135% |